Background: A Medicinal Gateway Where Mountains Meet the Sea
Fujian, situated on the southeastern coast of China, is a unique geographical intersection of mountains and sea that has served as a hub for cross-cultural exchange for millennia. In the grand history of maritime trade, medicine was not merely a commodity but a carrier of civilization. As a senior historical researcher, cross-analyzing digital archives from the Medicine, Health, and Foreign Affairs sections reveals that Fujian was not only an “Eastern Pharmaceutical Storehouse” for Southeast Asia but also a vital window for Western medical knowledge entering China.
From the exotic aromatics of Quanzhou Port in the Song and Yuan dynasties to the large-scale export of authentic local medicines in the Ming and Qing, and finally to the development of high-tech anti-cancer drugs today, Fujian’s medical history is a narrative of continuous cultural mutual learning.
Eastward Aromatics: Intercultural Trade in Song-Yuan Quanzhou
The Song and Yuan periods marked the zenith of Fujian’s overseas trade, with Quanzhou hailed as the largest port in the Eastern world.
1. Convergence of Exotic Materia Medica
Historical records show that medicines and spices accounted for a significant portion of imports via the Maritime Silk Road. Zhao Rushi, in his Song Dynasty work Zhu Fan Zhi, noted that among 47 major imported items, 23 were natural spices and aromatics, and 8 were drugs, together making up 66% of total imports. These included agarwood, cloves, sandalwood, frankincense, camphor, nutmeg, pepper, and hawksbill turtle shells.
2. Standardized Trade and Taxation
The Song court implemented strict management and monopoly systems for aromatic drugs. In 1087 AD, the Maritime Trade Bureau (Shibosi) was established in Quanzhou to oversee trade and collect “Chufen” (taxes). Records indicate that for imported aromatics, the government took 10% of high-value items and up to 30-40% of bulk items like sappanwood. This highly organized trade enriched the imperial treasury and significantly expanded the clinical toolkit of Traditional Chinese Medicine.
Digital Insight: The Epoch-Making Value of Su Song’s Work
Fujian was not just a trade hub but also a center for medical science. The Illustrated Materia Medica (Tu Jing Ben Cao), compiled by Su Song (1020-1101 AD) from Tong’an, represented a “digital” revolution in ancient medical history.
1. The Power of 933 Illustrations
In 1058 AD, Su Song was commissioned to lead a nationwide drug census—the largest systematic collection of specimens and illustrations in Chinese history, involving over 150 prefectures. The resulting work featured 933 woodblock drug illustrations, making it the world’s earliest printed pharmaceutical atlas.
2. Scientific Legacy
These illustrations provided a reliable basis for identifying plant species, genera, and families. Su Song’s systematic descriptions—ordering by seedlings, stems, leaves, flowers, fruits, and seeds—pioneered morphological studies in pharmacology. Joseph Needham, the renowned British scholar, praised it as “a masterpiece of pharmacological history with woodblock illustrations”.
Southern Dissemination: The Global Impact of Fujianese Medicines
While importing aromatics, Fujian also exported its own “authentic” (Di Dao) medicines to the world, particularly Southeast Asia.
1. Global Flow of Authentic Local Products
Fujianese products like Alisma (Zexie), Lotus seeds (Jianlian), Magnolia bark (Houpou), and smoked plums (Wumei) were exported globally with the “Jian” prefix as a mark of quality. For instance, “Jian Zexie” was famed for its size, firmness, and high starch content in Japan and Nanyang. During the Ming and Qing, the Zheng maritime group further expanded this reach, exporting dozens of varieties including ligusticum and licorice.
2. From Imperial Secret to International Icon
The most legendary export is Pianzihuang from Zhangzhou. Originating from a Ming imperial secret formula, it possesses miraculous anti-inflammatory properties. As Fujianese people migrated to Nanyang, Pianzihuang became the “miracle medicine of China” for overseas Chinese. By 1988, its export earnings exceeded US$10 million, leading the nation’s single-item Chinese medicine exports.
Modern Integration: Anti-Cancer Breakthroughs from Nature to Lab
The intercultural nature of Fujianese medicine has found new life in modern science, epitomized by the development of the anti-cancer drug Harringtonine.
1. Translating Folklore into Science
In the 1970s, during a provincial drug resource survey, researchers identified anti-cancer potential in the local Cephalotaxus plant. Working with national groups, Fujian scientists successfully isolated Harringtonine and Homoharringtonine.
2. Global Recognition of Clinical Data
Clinical studies showed that a combined Sino-Western therapy using these alkaloids for acute non-lymphocytic leukemia achieved a remission rate of 79.5% (some sources cite 68.4%), an international advanced standard at the time. In 1987, this research won the National Science and Technology Progress Award, marking Fujian’s successful transition from empirical tradition to modern biotechnology.
Significance for Modern Readers
Tracing the medicinal trajectory in the Fujian Provincial Annals offers several insights:
- Internationalization of Cultural Identity: TCM was never a closed system. As the start of the Maritime Silk Road, Fujian proves that TCM possesses immense competitiveness and vitality in cross-cultural exchange.
- The Power of Digital Preservation: Su Song’s “illustrated” spirit is the predecessor of today’s digital archiving. Precise recording is the foundation of scientific progress.
- Sustainable Resource Development: From wild collection to systematic cultivation (such as the artificial pollination of Amomum), Fujian’s medical history is a record of harmonious human-nature interaction.
Today, as we revisit these digital chronicles, we see not just yellowed drug maps, but the rebirth of an “Eastern Pharmaceutical Storehouse” bridging global mountains and seas through the lens of modern technology.